No effective immunotherapy exists yet for aggressive meningiomas, which have high morbidity and mortality rates. Our research focuses on developing and testing novel immunotherapy for aggressive meningiomas.
Research Interests
- Meningioma immune microenvironment
- Biological significance of cancer testes antigens in meningiomas
- Efficacy of T cell immunotherapies for meningiomas
- Significance of radiation on the meningioma immune microenvironment